Drug Enforcement Administration (DEA) - Tag
-
Marijuana Rescheduling: The Good, the Bad, and the ‘Wait-and-See’
Author: Leticia Maskell, Emerge Law Clerk News broke last week that U.S. Health and Human Services (HHS) sent a letter…
-
DEA Takes a Rare Step Forward for Telehealth
Author: Matt Brockmeier, Emerge Of Counsel Attorney The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (the Act) amended…
-
Why I Do What I Do: Representing patients with advanced illness
I represent Erinn Baldeschwiler in AIMS et al v DEA. Erinn is faced with advanced cancer, and the prospect of…
-
Court Hears Argument in Landmark Case Seeking to Open Access to Psilocybin Therapy
Nation’s First Legal Challenge to Allow Psilocybin Therapy in End-of-Life Care Under “Right-To-Try” Law Heard by the Ninth Circuit Court…
-
Petitioners’ Reply Brief Filed, Briefing Now Complete in AIMS et al v DEA
On Friday, 7/23, Petitioners filed their Reply Brief with the Ninth Circuit Court of Appeals in AIMS et al v…
-
Amici Curiae Supporting Case Seeking to Compel DEA to Allow Access to Psilocybin Therapy for Seriously Ill Patients
A Seattle palliative care physician, co-director of an integrative oncology clinic, and a number of his patients with advanced cancer…
-
Opening Access to Psilocybin Therapy for Seriously Ill Patients: The Petitioners’ Opening Brief in AIMS et al v DEA
Emerge Law Group is proud to represent a Seattle palliative care physician and co-director of an integrative oncology clinic, and…
-
Nation’s First Legal Challenge to Allow Psilocybin Therapy in End-of-Life Care Under “Right-To-Try” Laws Moves Forward
On behalf of terminally ill patients suffering anxiety and depression, we announce an advocacy effort to open access to psilocybin…